Adenosine Deaminase Deficiency Latest Advances

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

Journal: The New England journal of medicine

Published: October 15, 2025

Fatal Breakthrough Invasive Fungal Infection due to Aspergillus flavus in a Pediatric Patient with Adenosine Deaminase Deficiency.

Journal: Infectious diseases & clinical microbiology

Published: May 15, 2025

Prolonged diagnostic journey in delayed-onset adenosine deaminase deficiency.

Journal: Clinical immunology (Orlando, Fla.)

Published: October 01, 2024

Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.

Journal: Journal of clinical immunology

Published: April 30, 2024

A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

Journal: Pediatric neurology

Published: January 23, 2024

Successful management of delayed-onset adenosine deaminase deficiency with novel mutation.

Journal: Personalized medicine

Published: December 13, 2023

Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China.

Journal: World journal of pediatrics : WJP

Published: January 11, 2023

Updated Management Guidelines for Adenosine Deaminase Deficiency.

Journal: The journal of allergy and clinical immunology. In practice

Published: November 19, 2022

Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.

Journal: Immunity, inflammation and disease

Published: November 10, 2022

National experience with adenosine deaminase deficiency related SCID in Polish children.

Journal: Frontiers in immunology

Published: September 30, 2022

Balancing early detection of adenosine deaminase deficiency with overdiagnosis risk.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology

Published: September 05, 2022

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.

Journal: Nature medicine

Published: August 31, 2022

Adenosine Deaminase Deficiency Latest Advances

Find the Latest Research About Adenosine Deaminase Deficiency

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

Long-Term Safety and Efficacy of Gene Therapy for Adenosine Deaminase Deficiency.

Fatal Breakthrough Invasive Fungal Infection due to Aspergillus flavus in a Pediatric Patient with Adenosine Deaminase Deficiency.

Fatal Breakthrough Invasive Fungal Infection due to Aspergillus flavus in a Pediatric Patient with Adenosine Deaminase Deficiency.

Prolonged diagnostic journey in delayed-onset adenosine deaminase deficiency.

Prolonged diagnostic journey in delayed-onset adenosine deaminase deficiency.

Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.

Omenn Syndrome can Occur during Enzyme Therapy for Adenosine Deaminase Deficiency.

A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

A Clinical Neurological Approach to the Child With Adenosine Deaminase Deficiency.

Successful management of delayed-onset adenosine deaminase deficiency with novel mutation.

Successful management of delayed-onset adenosine deaminase deficiency with novel mutation.

Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China.

Delayed-onset adenosine deaminase deficiency with a novel synonymous mutation and a case series from China.

Updated Management Guidelines for Adenosine Deaminase Deficiency.

Updated Management Guidelines for Adenosine Deaminase Deficiency.

Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.

Safety and efficacy of elapegademase in patients with adenosine deaminase deficiency: A multicenter, open-label, single-arm, phase 3, and postmarketing clinical study.

National experience with adenosine deaminase deficiency related SCID in Polish children.

National experience with adenosine deaminase deficiency related SCID in Polish children.

Balancing early detection of adenosine deaminase deficiency with overdiagnosis risk.

Balancing early detection of adenosine deaminase deficiency with overdiagnosis risk.

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.

Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency.